We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Brenntag SE (PK) | USOTC:BNTGF | OTCMarkets | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 66.23 | 69.80 | 77.03 | 0.00 | 21:00:06 |
BC Partners, Bain Capital and Goldman Sachs Group Inc.'s (GS) private equity arm said Friday they had sold down a further 13.6% stake in German chemicals distributor Brenntag AG (BNR.XE) for EUR577.5 million.
The buyout trio, through acquisition vehicle Brachem Acquisition, sold 7 million shares at EUR82.50 each, and now have a combined stake of just below 14% remaining in Brenntag.
The funds bought Brenntag for more than EUR3 billion in 2006 with Bain and BC Partners having a 45% stake each and Goldman Sachs the remaining 10%. They sold an initial stake in the company when it floated in March 2010 at EUR50 a share.
The sales mean that Bain and BC Partners have made a 2.2 return on the cash put into the leveraged buyout and based on current market value their remaining stakes will add a further 0.7 to the money multiple.
Since its initial public offering in Frankfurt, and apart for just a week in May 2010, Brenntag's shares have traded well above its listing price. At 1215 GMT Friday they were trading at EUR84.84, down 2.2%.
-By Marietta Cauchi, Steffen Gosenheimer and Friedrich Geiger, Dow Jones Newswires; +44 7842 924; marietta.cauchi@dowjones.com
1 Year Brenntag (PK) Chart |
1 Month Brenntag (PK) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions